APA (7th ed.) Citation

Kirby, A. M., A'hern, R. P., D'ambrosio, C., Tanay, M., Syrigos, K. N., Rogers, S. J., . . . Harrington, K. J. (2006). Gefitinib (ZD1839, Iressa) as palliative treatment in recurrent or metastatic head and neck cancer. British Journal of Cancer, 94(5), 631. https://doi.org/10.1038/sj.bjc.6602999

Chicago Style (17th ed.) Citation

Kirby, A. M., et al. "Gefitinib (ZD1839, Iressa) as Palliative Treatment in Recurrent or Metastatic Head and Neck Cancer." British Journal of Cancer 94, no. 5 (2006): 631. https://doi.org/10.1038/sj.bjc.6602999.

MLA (9th ed.) Citation

Kirby, A. M., et al. "Gefitinib (ZD1839, Iressa) as Palliative Treatment in Recurrent or Metastatic Head and Neck Cancer." British Journal of Cancer, vol. 94, no. 5, 2006, p. 631, https://doi.org/10.1038/sj.bjc.6602999.